Singapore markets closed

GILD Jun 2024 87.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.01000.0000 (0.00%)
As of 10:07AM EDT. Market open.
Full screen
Previous close0.0100
Expiry date2024-06-21
Day's range0.0100 - 0.0100
Contract rangeN/A
Open interest1.38k

    Gilead Sciences Inc's Dividend Analysis

    Gilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date set for 2024-06-14. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Gilead Sciences Inc's dividend performance and assess its sustainability.

  • Business Wire

    New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment

    SANTA MONICA, Calif., June 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced results from three new analyses for Yescarta® (axicabtagene ciloleucel) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL), including both new clinical research and real-world evidence highlighting manufacturing and product characteristics of Yescarta, and outpatient administration of both Yescarta and Tecartus® (brexucabtagene autoleucel) at the 2024 European Hematology Association (EHA) Annual Co

  • Zacks

    Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

    The latest trading day saw Gilead Sciences (GILD) settling at $63.56, representing a -1.21% change from its previous close.